• 0
Shop Products Free shipping over $900000
slider
slider
slider
slider
slider
slider
slider
slider
slider
slider
slider

Brands QuickVue®

Respiratory Test Kit QuickVue® At-Home OTC COVID-19 Test 25 Tests CLIA Waived

Product # : 1191855 Class : MCKSN Distributor : RELIANCE INC Category : Test Kits Availability : Stocked

$0.00

Product Notices : This product may be non-returnable and/or require additional restocking fee.
Product Varient
- +
Add To Wishlist Add To Cart
Buy Now

Product Specifications

Product No. # 1191855
Manufacturer # 20398
Brand QuickVue®
Manufacturer Quidel
Country of Origin United States
Application Respiratory Test Kit
Number of Tests 25 Tests
Sample Type Nasal Swab Sample
Shipping Width 5.05
Shipping Height 2.5
Shipping Depth 8.85
Dimension UOM IC
Shipping Weight 0.52
Weight UOM LB
QTY Per Sell 25
Simply Medical Category Test Kits
Reading_Type Visual Read
Supply Manager Category Test Kits
Supply Manager Hierarchy
Clinical Laboratory>Test Kits>Respiratory Test Kit
California Prop 65 No
Legend Code No
Stock Status Stocked
Velocity Slow Selling
GTIN 3.00E+13
Ready to Sell Ready to sell
Other Popular Suggestions

#1204466

Respiratory Test Kit FlowFlex™ COVID-19 Antigen OTC 300 Tests per Case / 1 Test per Box CLIA Waived

CS - $1.36

#1186780

Respiratory Test Kit Status COVID-19 / Flu A and B 25 Tests

KT - $397.79
Features
  • Works for symptomatic and asymptomatic individuals
  • The QuickVue At-Home OTC COVID-19 test is intended for the qualitative detection of the nucleocapsid proteins from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 36 hours between tests.
  • Contains pre-filled vials – no counting of drops or errors in dispensing too much or too little of the liquid reagent solution
  • Positive results indicate the presence of viral foreign agent, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status.
  • Results may help limit the spread of COVID-19 to your family and others in your community.
  • In a clinical study, the QuickVue at Home OTC COVID-19 test identified positive cases 83.5% of the time, and identified negative cases 99.2% of the time.